Literature DB >> 16513087

Induction of Raf kinase inhibitor protein contributes to macrophage differentiation.

Marion M Schuierer1, Ursula Heilmeier, Alfred Boettcher, Peter Ugocsai, Anja K Bosserhoff, Gerd Schmitz, Thomas Langmann.   

Abstract

Differential gene expression analysis of human blood monocytes has identified the Raf kinase inhibitor protein (RKIP) as a continuously upregulated gene in macrophage and dendritic cell maturation. Using realtime RT-PCR and Western blot analysis we were able to confirm the initial DNA-microarray findings of RKIP induction on mRNA and protein levels. RKIP upregulation in primary cells and overexpression in THP-1 cells did not alter ERK activity but strongly reduced the amount of the NFkappaB subunit p65 in the nucleus. mRNA levels and cell surface expression of maturation markers including the integrin CD11c and the scavenger receptor CD36 were significantly increased in RKIP transfected THP-1 cells. Our data show for the first time that RKIP is upregulated during macrophage and dendritic cell differentiation on mRNA and protein levels and we conclude that RKIP contributes to the monocytic differentiation process via inhibition of the NFkappaB signaling cascade independent from the canonical Ras/Raf/MEK/ERK pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16513087     DOI: 10.1016/j.bbrc.2006.02.083

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Clinicopathological features and prognostic implications of Raf kinase inhibitor protein downregulation in tongue squamous cell carcinoma.

Authors:  Fengchun Hu; Xiaohua Chen; Xiqiang Liu; Cheng Wang; Lanhai Lv; Nan Xie; Tianyi Wang; Hongzhang Huang
Journal:  Oncol Lett       Date:  2015-07-15       Impact factor: 2.967

Review 2.  Interactions of RKIP with inflammatory signaling pathways.

Authors:  Jinming Zhao; Sally Wenzel
Journal:  Crit Rev Oncog       Date:  2014

3.  RKIP contributes to IFN-γ synthesis by CD8+ T cells after serial TCR triggering in systemic inflammatory response syndrome.

Authors:  Kyle T Wright; Anthony T Vella
Journal:  J Immunol       Date:  2013-06-12       Impact factor: 5.422

4.  The oxazolidinone derivative locostatin induces cytokine appeasement.

Authors:  Antoine Ménoret; Jeremy P McAleer; Soo-Mun Ngoi; Swagatam Ray; Nicholas A Eddy; Gabriel Fenteany; Seung-Joo Lee; Robert J Rossi; Bijay Mukherji; David L Allen; Nitya G Chakraborty; Anthony T Vella
Journal:  J Immunol       Date:  2009-11-16       Impact factor: 5.422

5.  Role of Raf-kinase inhibitor protein in colorectal cancer and its regulation by hydroxycamptothecine.

Authors:  Fang Nie; Jianguo Cao; Jinlu Tong; Mingming Zhu; Yuan Gao; Zhihua Ran
Journal:  J Biomed Sci       Date:  2015-07-16       Impact factor: 8.410

6.  Mapping the interactome of overexpressed RAF kinase inhibitor protein in a gastric cancer cell line.

Authors:  Huan Gu; Xianquan Zhan; Guiying Zhang; Lu Yan; William Cs Cho; Maoyu Li; Ting Liu; Zhuchu Chen
Journal:  BMC Cancer       Date:  2013-11-09       Impact factor: 4.430

7.  Molecular mechanism of hepatitis B virus (HBV) on suppression of raf kinase inhibitor protein (RKIP) expression.

Authors:  Xiao-Ke Cheng; Guo-Zheng Yu; Xiao-Dong Li; Xue-Qun Ren
Journal:  Oncotarget       Date:  2017-01-03

8.  Raf Kinase Inhibitory Protein protects cells against locostatin-mediated inhibition of migration.

Authors:  Anne N Shemon; Eva M Eves; Matthew C Clark; Gary Heil; Alexey Granovsky; Lingchun Zeng; Akira Imamoto; Shohei Koide; Marsha Rich Rosner
Journal:  PLoS One       Date:  2009-06-24       Impact factor: 3.240

9.  Raf Kinase Inhibitor Protein (RKIP) Inhibits Tumor Necrosis Factor-α (TNF-α) Induced Adhesion Molecules Expression in Vascular Smooth Muscle Bells by Suppressing (Nuclear Transcription Factor-κB (NF-kappaB) Pathway.

Authors:  Shen-Hong Jing; Xuan Gao; Bo Yu; Hong Qiao
Journal:  Med Sci Monit       Date:  2017-10-06

Review 10.  RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact.

Authors:  Apostolos Zaravinos; Benjamin Bonavida; Ekaterini Chatzaki; Stavroula Baritaki
Journal:  Cancers (Basel)       Date:  2018-08-24       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.